Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-mediated immunity in atherosclerosis

G K Hansson1

  • 1Centre for Molecular Medicine, Karolinska Hospital, Stockholm, Sweden. Goran.Hansson@cmm.ki.se

Current Opinion in Lipidology
|October 23, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans.

Journal of internal medicine·2020
Same author

Treatment with a Toll-like Receptor 7 ligand evokes protective immunity against atherosclerosis in hypercholesterolaemic mice.

Journal of internal medicine·2020
Same author

Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.

Journal of internal medicine·2017
Same author

Gene expression signatures, pathways and networks in carotid atherosclerosis.

Journal of internal medicine·2015
Same author

The changing face of atherosclerotic plaque inflammation.

Journal of internal medicine·2015
Same author

Inflammation and plaque vulnerability.

Journal of internal medicine·2015
Same journal

Editorial introduction.

Current opinion in lipidology·2026
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
See all related articles

Cellular immunity plays a role in atherosclerosis. Immune cells and their signaling molecules influence plaque development, with potential for protective effects through immunomodulation and immunization strategies.

Area of Science:

  • Cardiovascular immunology
  • Atherosclerosis research

Background:

  • Immunocompetent cells, including T-cells, infiltrate atherosclerotic plaques.
  • T-cells recognize oxidized low-density lipoprotein (LDL) and heat shock proteins, potentially serving as disease markers.
  • Immune cell-derived cytokines influence macrophage behavior, smooth muscle cells, and endothelial activation.

Purpose of the Study:

  • To review the role of cellular immunology in atherogenesis.
  • To analyze the complex interplay of immune signals in atherosclerosis.
  • To explore the potential of immunomodulation as a therapeutic strategy.

Main Methods:

  • Literature review of cellular immunology in atherosclerosis.
  • Analysis of immune cell infiltration and recognition within plaques.

Related Experiment Videos

  • Examination of cytokine-mediated effects on vascular cells.
  • Main Results:

    • Immune cells and their secreted factors significantly impact multiple stages of plaque development.
    • Complex positive and negative feedback loops exist within the immune system's response to atherosclerosis.
    • Experimental animal studies suggest immunomodulation and immunization can inhibit lesion formation.

    Conclusions:

    • Cellular immunity is intricately involved in the pathogenesis of atherosclerosis.
    • Understanding these immune mechanisms may reveal protective strategies against the disease.
    • Further investigation into immunomodulatory approaches holds promise for atherosclerosis treatment.